Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,386Revenue $M37.1Net Margin (%)-126.2Altman Z-Score16.1
Enterprise Value $M924EPS $-0.5Operating Margin %-154.3Piotroski F-Score4
P/E(ttm)--Beneish M-Score256Pre-tax Margin (%)-126.2Higher ROA y-yY
Price/Book3.210-y EBITDA Growth Rate %-33.0Quick Ratio9.4Cash flow > EarningsY
Price/Sales40.65-y EBITDA Growth Rate %-3.2Current Ratio9.4Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-16.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-18.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M137ROIC % (ttm)-616.6Gross Margin Increase y-yN

Gurus Latest Trades with ACHN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
ACHNFirst Eagle Investment 2014-03-31 Sold Out -0.01%$3.08 - $4.2
$ 10.15190%Sold Out0
ACHNFirst Eagle Investment 2013-12-31 Buy 0.01%$2.43 - $3.46
$ 10.15250%New holding600,000
ACHNGeorge Soros 2012-06-30 Sold Out -0.04%$5.94 - $10.95
$ 10.1538%Sold Out0
ACHNGeorge Soros 2012-03-31 Reduce-0.09%$7.71 - $12.375
$ 10.156%Reduce 50.00%250,000
ACHNGeorge Soros 2011-12-31 Add0.16%$4.01 - $8
$ 10.1565%Add 2132.14%500,000
ACHNGeorge Soros 2011-09-30 Buy $4.63 - $8.31
$ 10.1559%New holding22,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ACHN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

ACHN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
VITULLO NICOLEDirector 2015-11-11Sell550,000$10.17-0.2view
VITULLO NICOLEDirector 2015-09-25Sell9,310$8.2223.48view
VITULLO NICOLEDirector 2015-08-14Sell37,843$7.5135.15view
Fenton Mary KayEVP and CFO 2015-01-23Sell13,125$16-36.56view
Deshpande MilindPresident and CEO 2015-01-21Sell100,000$15-32.33view
RA CAPITAL MANAGEMENT, LLC 2014-09-30Sell1,332,014$10.2-0.49view
RA CAPITAL MANAGEMENT, LLC10% Owner 2014-09-26Sell2,372,915$11.17-9.13view
RA CAPITAL MANAGEMENT, LLC10% Owner 2014-09-23Sell2,595,071$11.29-10.1view
RA CAPITAL MANAGEMENT, LLC10% Owner 2014-09-11Sell1,704,362$20356.3-99.95view
RA CAPITAL MANAGEMENT, LLC10% Owner 2014-09-11Sell1,704,362$12.45-18.47view

Quarterly/Annual Reports about ACHN:

    News about ACHN:

    Articles On GuruFocus.com
    UBS and JMP Securities Downgrade Achillion Pharmaceuticals Inc.(ACHN) Following Johnson & Johnson (J May 21 2015 
    Dycom Industries (DY) Surpasses Estimates; Achillion Pharma (ACHN) Inks Mega-Deal with Janssen May 20 2015 
    Gilead Experiencing Bumpy Ride Despite Strong Fundamentals Apr 03 2015 
    Achillion Pharmaceuticals Stock Soars Following Successful Mid-Stage Hep C Drug Combo Trial Feb 10 2015 
    Hall of Fame/ Hall of Shame: The Best and Worst Recommendations of 2014 Jan 09 2015 
    Weekly CEO Sells Highlight: Achillion Pharmaceutical Inc, Protective Life Corp, Host Hotels & Resort Aug 25 2014 
    Top 4 Insider Buys of Last Week Jun 10 2013 
    comment on ACHN Mar 15 2013 
    comment on ACHN Mar 09 2013 
    Achillion Will Surge If New Drug Is Successful Apr 21 2012 

    More From Other Websites
    What Do Hedge Funds Think of Alamos Gold Inc (AGI)? Nov 28 2015
    4 Key FDA Decisions Expected By Year End Nov 28 2015
    Bears Must Bear With Upward Drift Nov 25 2015
    Getting That Holiday Trading Feeling Nov 25 2015
    SurModics Buys Balloon Catheter Maker Creagh Medical Nov 23 2015
    Fate Therapeutics (FATE) Catches Eye: Stock Moves 5.3% Higher Nov 18 2015
    Lilly's Diabetes Drug Makes It a Turner Medical Fund Pick Nov 17 2015
    Achillion Pharmaceuticals (ACHN) Stock Has 40% Potential Upside Nov 17 2015
    Achillion Pharmaceuticals (ACHN) Shares March Higher, Can It Continue? Nov 12 2015
    Why Achillion Pharmaceuticals (ACHN) Could Be Positioned for a Surge? Nov 12 2015
    Aegerion Tops Q3 Earnings, Revenues, PCSK9s Hit Juxtapid Nov 10 2015
    Achillion beats 3Q profit forecasts Nov 05 2015
    Achillion beats 3Q profit forecasts Nov 05 2015
    Achillion Reports Third Quarter And Nine Month 2015 Financial Results Nov 05 2015
    ACHILLION PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 05 2015
    Achillion Reports Third Quarter And Nine Month 2015 Financial Results Nov 05 2015
    Achillion Announces Upcoming Oral Presentation at the 57th Annual Meeting of the American Society of... Nov 05 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)